Adding Zynyz to carboplatin and paclitaxel prolonged the survival without progression in chemotherapy-naive recurrent or ...

High TILs may predict which patients with early HER2-positive breast cancer may have a reduced risk for disease relapse or ...

Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial ...

Patients with previously untreated, high-risk locally advanced cervical cancer experienced improved survival when treated ...

Study findings were mixed regarding the postsurgical combination of Keytruda and chemotherapy with or without radiation among ...